SOUTH SAN FRANCISCO,
California and VANCOUVER,
Canada, June 1, 2023 /PRNewswire/ - ESSA Pharma
Inc. ("ESSA", or the "Company") (NASDAQ: EPIX), a clinical-stage
pharmaceutical company focused on developing novel therapies for
the treatment of prostate cancer, today announced that the Company
will be presenting at the Jefferies Healthcare Conference on
Thursday, June 8, 2023 at
8:00 a.m. Eastern Time in
New York.
David R.
Parkinson, President and Chief Executive Officer of ESSA
Pharma; Peter Virsik, ESSA's Chief
Operating Officer; and David S.
Wood, ESSA's Chief Financial Officer, will host and
participate in one-on-one meetings.
A live webcast of the Jefferies presentation can
be accessed in the Investors/Events & Presentations section of
ESSA's website at www.essapharma.com. Following the event, the
webcast will be archived on the ESSA website for 90 days.
About ESSA Pharma Inc.
ESSA is a clinical-stage pharmaceutical company
focused on developing novel and proprietary therapies for the
treatment of patients with prostate cancer. For more information,
please visit www.essapharma.com and follow us on Twitter under
@ESSAPharma.
View original
content:https://www.prnewswire.com/news-releases/essa-pharma-to-present-at-2023-jefferies-healthcare-conference-301837354.html
SOURCE ESSA Pharma Inc